Diabetic amyotrophy in an adolescent responsive to intravenous immunoglobulin.
We report the case of a 13-year-old boy with poorly controlled type 2 diabetes mellitus who developed severe diabetic amyotrophy, which progressed over a few months but demonstrated rapid recovery after administration of intravenous immunoglobulin. This report highlights the importance of monitoring adolescents for even the rare neurologic complications of diabetes mellitus most commonly encountered in adults, and supports the need for well-designed trials using immunomodulatory therapies in diabetic amyotrophy.
Fernandes Filho
Jose Americo
JA
Department of Neurology, University Hospitals of Cleveland/Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, Ohio 44106, USA.
Nathan
Brandon M
BM
Palmert
Mark R
MR
Katirji
Bashar
B
D000293:Adolescent; D003929:Diabetic Neuropathies / Q000503:physiopathology / Q000628:therapy*; D004558:Electric Stimulation / Q000379:methods; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D009431:Neural Conduction / Q000502:physiology / Q000528:radiation effects; D010525:Peripheral Nerves / Q000503:physiopathology / Q000528:radiation effects; D011930:Reaction Time / Q000502:physiology
D016756:Immunoglobulins, Intravenous